Trans-10,cis-12 Conjugated linoleic acid promotes bone formation by inhibiting adipogenesis by peroxisome proliferator activated receptor-γ-dependent mechanisms and by directly enhancing osteoblastogenesis from bone marrow mesenchymal stem cells

Journal of Nutritional Biochemistry

Volumn 24, Issue 4, 2013, Pages 672-679

  Kim, Jonggun ^a   Park, Yooheon ^a   Lee, Seong Ho ^b   Park, Yeonhwa ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

Adipogenesis; Cis 12 CLA; Cis 9; CLA; Osteoblastogenesis; Trans 10; Trans 11 CLA

Indexed keywords

CALCIUM; CONJUGATED LINOLEIC ACID; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRANSCRIPTION FACTOR RUNX2;

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; BONE MARROW MESENCHYMAL STEM CELL; BONE MASS; CELL DIFFERENTIATION; CIS TRANS ISOMERISM; CONTROLLED STUDY; DNA FRAGMENTATION; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OBESITY; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; PROTEIN EXPRESSION;

ADIPOGENESIS; ANIMALS; BONE DEVELOPMENT; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL LINE; LINOLEIC ACIDS, CONJUGATED; MESENCHYMAL STROMAL CELLS; MICE; OSTEOBLASTS; PPAR GAMMA;

MURINAE;

EID: 84875065100     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2012.03.017     Document Type: Article

References (90)

1. Ammann P., Rizzoli R. Bone strength and its determinants. Osteoporos Int 2003, 14(Suppl. 3):S13-S18.
2. National Osteoporosis Foundation Fast facts 2005, Available at:, (accessed May 18, 2012). http://www.nof.org/node/40.
3. Nelson-Dooley C., Della-Fera M.A., Hamrick M., Baile C.A. Novel treatments for obesity and osteoporosis: targeting apoptotic pathways in adipocytes. Curr Med Chem 2005, 12:2215-2225.
4. Komi J., Lankinen K.S., DeGregorio M., Heikkinen J., Saarikoski S., Tuppurainen M., et al. Effects of ospemifene and raloxifene on biochemical markers of bone turnover in postmenopausal women. J Bone Miner Metab 2006, 24:314-318.
5. Seeman E. Reduced bone formation and increased bone resorption: Rational targets for the treatment of osteoporosis. Osteoporos Int 2003, 14(Suppl. 3):S2-S8.
6. Kronenberg H.M. Developmental regulation of the growth plate. Nature 2003, 423:332-336.
7. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
8. Mackie E.J. Osteoblasts: novel roles in orchestration of skeletal architecture. Int J Biochem Cell Biol 2003, 35:1301-1305.
9. Nuttall M.E., Gimble J.M. Is there a therapeutic opportunity to either prevent or treat osteopenic disorders by inhibiting marrow adipogenesis?. Bone 2000, 27:177-184.
10. Rzonca S.O., Suva L.J., Gaddy D., Montague D.C., Lecka-Czernik B. Bone is a target for the antidiabetic compound rosiglitazone. Endocrinology 2004, 145:401-406.
11. Takada I., Suzawa M., Matsumoto K., Kato S. Suppression of PPAR transactivation switches cell fate of bone marrow stem cells from adipocytes into osteoblasts. Ann N Y Acad Sci 2007, 1116:182-195.
12. Akune T., Ohba S., Kamekura S., Yamaguchi M., Chung U.I., Kubota N., et al. PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J Clin Invest 2004, 113:846-855.
13. Gimble J.M., Robinson C.E., Wu X., Kelly K.A., Rodriguez B.R., Kliewer S.A., et al. Peroxisome proliferator-activated receptor-gamma activation by thiazolidinediones induces adipogenesis in bone marrow stromal cells. Mol Pharmacol 1996, 50:1087-1094.
14. Park Y., Pariza M.W. Mechanisms of body fat modulation by conjugated linoleic acid (CLA). Food Res Int 2007, 40:311-323.
15. Park Y., Albright K.J., Liu W., Storkson J.M., Cook M.E., Pariza M.W. Effect of conjugated linoleic acid on body composition in mice. Lipids 1997, 32:853-858.
16. Kepler C.R., Hirons K.P., McNeill J.J., Tove S.B. Intermediates and products of the biohydrogenation of linoleic acid by butyrinvibrio fibrisolvens. J Biol Chem 1966, 241:1350-1354.
17. Pariza M.W., Park Y., Cook M.E. The biologically active isomers of conjugated linoleic acid. Prog Lipid Res 2001, 40:283-298.
18. Pariza M.W. Perspective on the safety and effectiveness of conjugated linoleic acid. Am J Clin Nutr 2004, 79:1132S-1136S.
19. Ip C., Dong Y., Ip M.M., Banni S., Carta G., Angioni E., et al. Conjugated linoleic acid isomers and mammary cancer prevention. Nutr Cancer 2002, 43:52-58.
20. Masso-Welch P.A., Zangani D., Ip C., Vaughan M.M., Shoemaker S.F., McGee S.O., et al. Isomers of conjugated linoleic acid differ in their effects on angiogenesis and survival of mouse mammary adipose vasculature. J Nutr 2004, 134:299-307.
21. Valeille K., Gripois D., Blouquit M.F., Souidi M., Riottot M., Bouthegourd J.C., et al. Lipid atherogenic risk markers can be more favourably influenced by the cis-9, trans-11-octadecadienoate isomer than a conjugated linoleic acid mixture or fish oil in hamsters. Br J Nutr 2004, 91:191-199.
22. Park Y., Storkson J.M., Albright K.J., Liu W., Pariza M.W. Evidence that the trans-10, cis-12 isomer of conjugated linoleic acid induces body composition changes in mice. Lipids 1999, 34:235-241.
23. Park Y., Albright K.J., Storkson J.M., Liu W., Cook M.E., Pariza M.W. Changes in body composition in mice during feeding and withdrawal of conjugated linoleic acid. Lipids 1999, 34:243-248.
24. Park Y., Pariza M.W., Park Y. Co-supplementation of dietary calcium and conjugated linoleic acid (CLA) improves bone mass in mice. J Food Sci 2008, 73:C556-C560.
25. Brown J.M., Boysen M.S., Jensen S.S., Morrison R.F., Storkson J., Lea-Currie R., et al. Isomer-specific regulation of metabolism and PPARgamma signaling by CLA in human preadipocytes. J Lipid Res 2003, 44:1287-1300.
26. Granlund L., Juvet L.K., Pedersen J.I., Nebb H.I. Trans10, cis12-conjugated linoleic acid prevents triacylglycerol accumulation in adipocytes by acting as a PPARgamma modulator. J Lipid Res 2003, 44:1441-1452.
27. Rahman M.M., Halade G.V., Williams P.J., Fernandes G. t10c12-CLA maintains higher bone mineral density during aging by modulating osteoclastogenesis and bone marrow adiposity. J Cell Physiol 2011, 226:2406-2414.
28. Halade G.V., Rahman M.M., Williams P.J., Fernandes G. Combination of conjugated linoleic acid with fish oil prevents age-associated bone marrow adiposity in C57Bl/6J mice. J Nutr Biochem 2011, 22:459-469.
29. Zhou H., Yang X., Wang N., Zhang Y., Cai G. Tigogenin inhibits adipocytic differentiation and induces osteoblastic differentiation in mouse bone marrow stromal cells. Mol Cell Endocrinol 2007, 270:17-22.
30. Hillel J.G. An improved automated procedure for the determination of calcium in biological specimens. Anal Biochem 1967, 18:521-531.
31. Mizutani A., Sugiyama I., Kuno E., Matsunaga S., Tsukagoshi N. Expression of matrix metalloproteinases during ascorbate-induced differentiation of osteoblastic MC3T3-E1 cells. J Bone Miner Res 2001, 16:2043-2049.
32. Fajas L., Debril M.B., Auwerx J. Peroxisome proliferator-activated receptor-gamma: from adipogenesis to carcinogenesis. J Mol Endocrinol 2001, 27:1-9.
33. Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., Deguchi K., et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997, 89:755-764.
34. Harada H., Tagashira S., Fujiwara M., Ogawa S., Katsumata T., Yamaguchi A., et al. Cbfa1 isoforms exert functional differences in osteoblast differentiation. J Biol Chem 1999, 274:6972-6978.
35. Owen T.A., Aronow M., Shalhoub V., Barone L.M., Wilming L., Tassinari M.S., et al. Progressive development of the rat osteoblast phenotype in vitro: Reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol 1990, 143:420-430.
36. Whyte M.P. Physiological role of alkaline phosphatase explored in hypophosphatasia. Ann N Y Acad Sci 2010, 1192:190-200.
37. Pan L.C., Price P.A. The propeptide of rat bone gamma-carboxyglutamic acid protein shares homology with other vitamin K-dependent protein precursors. Proc Natl Acad Sci U S A 1985, 82:6109-6113.
38. Gerstenfeld L.C., Chipman S.D., Glowacki J., Lian J.B. Expression of differentiated function by mineralizing cultures of chicken osteoblasts. Dev Biol 1987, 122:49-60.
39. Suda T., Takahashi N., Udagawa N., Jimi E., Gillespie M.T., Martin T.J. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 1999, 20:345-357.
40. Jeon M.J., Kim J.A., Kwon S.H., Kim S.W., Park K.S., Park S.W., et al. Activation of peroxisome proliferator-activated receptor-gamma inhibits the Runx2-mediated transcription of osteocalcin in osteoblasts. J Biol Chem 2003, 278:23270-23277.
41. Platt I.D., El-Sohemy A. Regulation of osteoblast and adipocyte differentiation from human mesenchymal stem cells by conjugated linoleic acid. J Nutr Biochem 2009, 20:956-964.
42. Park Y. Conjugated linoleic acid (CLA): good or bad trans fat?. J Food Comp Anal 2009, 22S:S4-S12.
43. Rosen E.D., Spiegelman B.M. PPARgamma: a nuclear regulator of metabolism, differentiation, and cell growth. J Biol Chem 2001, 276:37731-37734.
44. Rosen E.D., Sarraf P., Troy A.E., Bradwin G., Moore K., Milstone D.S., et al. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell 1999, 4:611-617.
45. Evans M., Park Y., Pariza M., Curtis L., Kuebler B., McIntosh M. trans-10, cis-12 conjugated linoleic acid reduces triglyceride content while differentially affecting peroxisome proliferator activated receptor gamma2 and aP2 expression in 3T3-L1 preadipocytes. Lipids 2001, 36:1223-1232.
46. Zhou X.R., Sun C.H., Liu J.R., Zhao D. Dietary conjugated linoleic acid increases PPAR gamma gene expression in adipose tissue of obese rat, and improves insulin resistance. Growth Horm IGF Res 2008, 18:361-368.
47. Houseknecht K.L., Vanden Heuvel J.P., Moya-Camarena S.Y., Portocarrero C.P., Peck L.W., Nickel K.P., et al. Dietary conjugated linoleic acid normalizes impaired glucose tolerance in the zucker diabetic fatty fa/fa rat. Biochem Biophys Res Commun 1998, 244:678-682.
48. Tsuboyama-Kasaoka N., Takahashi M., Tanemura K., Kim H.J., Tange T., Okuyama H., et al. Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice. Diabetes 2000, 49:1534-1542.
49. Hargrave K.M., Meyer B.J., Li C., Azain M.J., Baile C.A., Miner J.L. Influence of dietary conjugated linoleic acid and fat source on body fat and apoptosis in mice. Obes Res 2004, 12:1435-1444.
50. Li B. Bone morphogenetic protein-smad pathway as drug targets for osteoporosis and cancer therapy. Endocr Metab Immune Disord Drug Targets 2008, 8:208-219.
51. Arnold S.J., Maretto S., Islam A., Bikoff E.K., Robertson E.J. Dose-dependent Smad1, Smad5 and Smad8 signaling in the early mouse embryo. Dev Biol 2006, 296:104-118.
52. Binato R., Alvarez Martinez C.E., Pizzatti L., Robert B., Abdelhay E. SMAD 8 binding to mice Msx1 basal promoter is required for transcriptional activation. Biochem J 2006, 393:141-150.
53. Bennett C.N., Longo K.A., Wright W.S., Suva L.J., Lane T.F., Hankenson K.D., et al. Regulation of osteoblastogenesis and bone mass by Wnt10b. Proc Natl Acad Sci U S A 2005, 102:3324-3329.
54. Ross S.E., Hemati N., Longo K.A., Bennett C.N., Lucas P.C., Erickson R.L., et al. Inhibition of adipogenesis by wnt signaling. Science 2000, 289:950-953.
55. Nakamura Y.K., Omaye S.T. Conjugated linoleic acid isomers' roles in the regulation of PPAR-gamma and NF-kappaB DNA binding and subsequent expression of antioxidant enzymes in human umbilical vein endothelial cells. Nutrition 2009, 25:800-811.
56. Hommelberg P.P., Plat J., Remels A.H., van Essen A.L., Kelders M.C., Mensink R.P., et al. trans-10, cis-12 conjugated linoleic acid inhibits skeletal muscle differentiation and GLUT4 expression independently from NF-kappaB activation. Mol Nutr Food Res 2010, 54:1763-1772.
57. Chung S., Brown J.M., Provo J.N., Hopkins R., McIntosh M.K. Conjugated linoleic acid promotes human adipocyte insulin resistance through NFkappaB-dependent cytokine production. J Biol Chem 2005, 280:38445-38456.
58. Kim D.I., Kim K.H., Kang J.H., Jung E.M., Kim S.S., Jeung E.B., et al. Trans-10, cis-12-conjugated linoleic acid modulates NF-kappaB activation and TNF-alpha production in porcine peripheral blood mononuclear cells via a PPARgamma-dependent pathway. Br J Nutr 2011, 105:1329-1336.
59. Cho H.H., Shin K.K., Kim Y.J., Song J.S., Kim J.M., Bae Y.C., et al. NF-kappaB activation stimulates osteogenic differentiation of mesenchymal stem cells derived from human adipose tissue by increasing TAZ expression. J Cell Physiol 2010, 223:168-177.
60. Stachowska E., Dolegowska B., Dziedziejko V., Rybicka M., Kaczmarczyk M., Bober J., et al. Prostaglandin E2 (PGE2) and thromboxane A2 (TXA2) synthesis is regulated by conjugated linoleic acids (CLA) in human macrophages. J Physiol Pharmacol 2009, 60:77-85.
61. Kennedy A., Chung S., LaPoint K., Fabiyi O., McIntosh M.K. Trans-10, cis-12 conjugated linoleic acid antagonizes ligand-dependent PPARgamma activity in primary cultures of human adipocytes. J Nutr 2008, 138:455-461.
62. Boyle W.J., Simonet W.S., Lacey D.L. Osteoclast differentiation and activation. Nature 2003, 423:337-342.
63. Martin T.J., Ng K.W. Mechanisms by which cells of the osteoblast lineage control osteoclast formation and activity. J Cell Biochem 1994, 56:357-366.
64. Shockley K.R., Lazarenko O.P., Czernik P.J., Rosen C.J., Churchill G.A., Lecka-Czernik B. PPARgamma2 nuclear receptor controls multiple regulatory pathways of osteoblast differentiation from marrow mesenchymal stem cells. J Cell Biochem 2009, 106:232-246.
65. Krause U., Harris S., Green A., Ylostalo J., Zeitouni S., Lee N., et al. Pharmaceutical modulation of canonical wnt signaling in multipotent stromal cells for improved osteoinductive therapy. Proc Natl Acad Sci U S A 2010, 107:4147-4152.
66. Fu M., Zhang J., Lin Yg Y., Zhu X., Willson T.M., Chen Y.E. Activation of peroxisome proliferator-activated receptor gamma inhibits osteoprotegerin gene expression in human aortic smooth muscle cells. Biochem Biophys Res Commun 2002, 294:597-601.
67. Rahman M.M., Bhattacharya A., Fernandes G. Conjugated linoleic acid inhibits osteoclast differentiation of RAW264.7 cells by modulating RANKL signaling. J Lipid Res 2006, 47:1739-1748.
68. Dilzer A., Park Y. Implication of conjugated linoleic acid (CLA) in human health. Crit Rev Food Sci Nutr 2012, 52:488-513.
69. Kreider R.B., Ferreira M.P., Greenwood M., Wilson M., Almada A.L. Effects of conjugated linoleic acid supplementation during resistance training on body composition, bone density, strength, and selected hematological markers. J Strength Cond Res 2002, 16:325-334.
70. Brownbill R.A., Petrosian M., Ilich J.Z. Association between dietary conjugated linoleic acid and bone mineral density in postmenopausal women. J Am Coll Nutr 2005, 24:177-181.
71. Terpstra A.H. Differences between humans and mice in efficacy of the body fat lowering effect of conjugated linoleic acid: Role of metabolic rate. J Nutr 2001, 131:2067-2068.
72. Zemel M.B. Calcium modulation of hypertension and obesity: Mechanisms and implications. J Am Coll Nutr 2001, 20:428S-435S. [discussion 440S-442S].
73. Zemel M.B., Shi H., Greer B., Dirienzo D., Zemel P.C. Regulation of adiposity by dietary calcium. FASEB J 2000, 14:1132-1138.
74. Park Y., Terk M., Park Y. Interaction between dietary conjugated linoleic acid and calcium supplementation affecting bone and fat mass. J Bone Miner Metab 2011, 29:268-278.
75. Kelly O., Cusack S., Jewell C., Cashman K.D. The effect of polyunsaturated fatty acids, including conjugated linoleic acid, on calcium absorption and bone metabolism and composition in young growing rats. Br J Nutr 2003, 90:743-750.
76. Roche H.M., Terres A.M., Black I.B., Gibney M.J., Kelleher D. Fatty acids and epithelial permeability: effect of conjugated linoleic acid in caco-2 cells. Gut 2001, 48:797-802.
77. Krolner B., Toft B. Vertebral bone loss: an unheeded side effect of therapeutic bed rest. Clin Sci (Lond) 1983, 64:537-540.
78. Pigozzi F., Rizzo M., Giombini A., Parisi A., Fagnani F., Borrione P. Bone mineral density and sport: effect of physical activity. J Sports Med Phys Fitness 2009, 49:177-183.
79. Wolff I., van Croonenborg J.J., Kemper H.C., Kostense P.J., Twisk J.W. The effect of exercise training programs on bone mass: a meta-analysis of published controlled trials in pre- and postmenopausal women. Osteoporos Int 1999, 9:1-12.
80. Chen Y., Wang S., Bu S., Wang Y., Duan Y., Yang S. Treadmill training prevents bone loss by inhibition of PPARgamma expression but not promoting of Runx2 expression in ovariectomized rats. Eur J Appl Physiol 2011, 111:1759-1767.
81. Park Y., McGuire M.K., Behr R., McGuire M.A., Evans M.A., Shultz T.D. High-fat dairy product consumption increases delta 9c,11t-18:2 (rumenic acid) and total lipid concentrations of human milk. Lipids 1999, 34:543-549.
82. Ritzenthaler K., McGuire M., Falen R., Shultz T., McGuire M. Estimation of conjugated linoleic acid (CLA) intake. FASEB J 1998, 12:A527.
83. Herbel B.K., McGuire M.K., McGuire M.A., Shultz T.D. Safflower oil consumption does not increase plasma conjugated linoleic acid concentrations in humans. Am J Clin Nutr 1998, 67:332-337.
84. Jaudszus A., Krokowski M., Mockel P., Darcan Y., Avagyan A., Matricardi P., et al. Cis-9, trans-11-conjugated linoleic acid inhibits allergic sensitization and airway inflammation via a PPARgamma-related mechanism in mice. J Nutr 2008, 138:1336-1342.
85. Jaudszus A., Foerster M., Kroegel C., Wolf I., Jahreis G. Cis-9, trans-11-CLA exerts anti-inflammatory effects in human bronchial epithelial cells and eosinophils: Comparison to trans-10, cis-12-CLA and to linoleic acid. Biochim Biophys Acta 2005, 1737:111-118.
86. Platt I., El-Sohemy A. Effects of 9cis,11trans and 10trans,12cis CLA on osteoclast formation and activity from human CD14+ monocytes. Lipids Health Dis 2009, 8:15.
87. Murphy E.F., Hooiveld G.J., Muller M., Calogero R.A., Cashman K.D. Conjugated linoleic acid alters global gene expression in human intestinal-like caco-2 cells in an isomer-specific manner. J Nutr 2007, 137:2359-2365.
88. Jewell C., Cashman K.D. The effect of conjugated linoleic acid and medium-chain fatty acids on transepithelial calcium transport in human intestinal-like caco-2 cells. Br J Nutr 2003, 89:639-647.
89. Park Y.H., Park Y. Effects of conjugated linoleic acid (CLA) on calcium homeostasis in ovariectomized mice. FASEB J 2010, 24:lb377.
90. Jewell C., Cusack S., Cashman K.D. The effect of conjugated linoleic acid on transepithelial calcium transport and mediators of paracellular permeability in human intestinal-like CaCo-2 cells. Prostaglandins Leukot Essent Fatty Acids 2005, 72:163-171.